iRhythm Holdings (IRTC) Liabilities and Shareholders Equity (2015 - 2026)
iRhythm Holdings (IRTC) reported Liabilities and Shareholders Equity of $1.0 billion for Q1 2026, up 8.67% year-over-year from $926.1 million in Q1 2025, and down 1.34% on a QoQ basis from $1.0 billion in Q4 2025.
iRhythm Holdings (IRTC) has 12 years of Liabilities and Shareholders Equity data on file, last reported at $1.0 billion in Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 8.67% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 billion (up 8.12% YoY) and the FY2025 annual result came in at $1.0 billion, up 9.51% from the prior year.
- Liabilities and Shareholders Equity eased to $1.0 billion in Q1 2026 per IRTC's latest filing, from $1.0 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $1.0 billion in Q4 2025 and bottomed at $421.7 million in Q1 2023.
- The 5-year median for Liabilities and Shareholders Equity is $909.7 million (2024), against an average of $709.3 million.
- The widest annual swing landed in 2022, when Liabilities and Shareholders Equity dropped 10.4%; it then surged 115.73% in 2024.
- Tracing IRTC's Liabilities and Shareholders Equity over 5 years: stood at $448.2 million in 2022, then declined by 3.36% to $433.1 million in 2023, then soared by 115.04% to $931.4 million in 2024, then advanced by 9.51% to $1.0 billion in 2025, then fell by 1.34% to $1.0 billion in 2026.
- Per Business Quant, the three latest IRTC Liabilities and Shareholders Equity figures stand at $1.0 billion (Q1 2026), $1.0 billion (Q4 2025), and $995.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Bn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 995.21 Mn |
| Jun 30, 2025 | 964.03 Mn |
| Mar 31, 2025 | 926.10 Mn |
| Dec 31, 2024 | 931.45 Mn |
| Sep 30, 2024 | 909.69 Mn |
| Jun 30, 2024 | 919.19 Mn |
| Mar 31, 2024 | 909.76 Mn |
| Dec 31, 2023 | 433.14 Mn |
| Sep 30, 2023 | 439.77 Mn |
| Jun 30, 2023 | 429.49 Mn |
| Mar 31, 2023 | 421.70 Mn |
| Dec 31, 2022 | 448.22 Mn |
| Sep 30, 2022 | 440.39 Mn |
| Jun 30, 2022 | 435.69 Mn |
| Mar 31, 2022 | 428.72 Mn |
| Dec 31, 2021 | 462.97 Mn |
| Sep 30, 2021 | 480.25 Mn |
| Jun 30, 2021 | 485.22 Mn |
| Mar 31, 2021 | 478.49 Mn |
| Dec 31, 2020 | 511.74 Mn |
| Sep 30, 2020 | 497.20 Mn |
| Jun 30, 2020 | 276.22 Mn |
| Mar 31, 2020 | 282.94 Mn |
| Dec 31, 2019 | 306.21 Mn |
| Sep 30, 2019 | 310.08 Mn |
| Jun 30, 2019 | 205.27 Mn |
| Mar 31, 2019 | 115.23 Mn |
| Dec 31, 2018 | 117.52 Mn |
| Sep 30, 2018 | 118.50 Mn |
| Jun 30, 2018 | 119.89 Mn |
| Mar 31, 2018 | 122.30 Mn |
| Dec 31, 2017 | 133.38 Mn |
| Sep 30, 2017 | 133.66 Mn |
| Jun 30, 2017 | 134.38 Mn |
| Mar 31, 2017 | 132.80 Mn |
| Dec 31, 2016 | 138.16 Mn |
| Sep 30, 2016 | 27.38 Mn |
| Dec 31, 2015 | 37.87 Mn |